CJC-1295 with DAC is a GHRH analog incorporating a drug-affinity complex studied for extended growth-hormone-axis signalling in research.
CJC-1295 with DAC is a synthetic analog of growth-hormone-releasing hormone (GHRH) modified with a drug-affinity complex (DAC) that binds albumin to extend its circulating half-life. It is studied in research contexts related to the growth-hormone axis and GHRH receptor signalling, with emphasis on prolonged receptor engagement.
GHRH-analog research generally examines effects on growth-hormone pulsatility, downstream IGF-1 signalling, and receptor activity. The DAC modification is investigated for sustained action compared to shorter-acting analogs, with data drawn from preclinical and early research.
Studied for GHRH receptor effects on growth-hormone-axis activity in research models.
Investigated for prolonged action from the albumin-binding drug-affinity complex modification.
Examined for downstream IGF-1 signalling associated with GHRH receptor stimulation in research.
Characterized through assays defining its GHRH receptor agonism and signalling profile.
Bring the vial (10 mg) and bacteriostatic water to room temperature.
Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.
Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.
Studied together combining GHRH and GH-secretagogue pathways in growth-axis research models.
Explored in research examining GHRH signalling alongside local IGF-receptor activity.
Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.
It is a GHRH analog with a drug-affinity complex that binds albumin to extend half-life. It is studied for prolonged growth-hormone-axis and GHRH receptor signalling in research.
The drug-affinity complex allows albumin binding, extending circulation time so the analog is studied for sustained action compared to non-DAC versions.
It is studied in the context of GHRH receptor activity, growth-hormone-axis signalling, and downstream IGF-1 pathways within preclinical and early research models.
See the product, or build a stack around it.
View product →Open Stack-Builder →
You must be at least 21 years old to enter this website.
By clicking "Confirm & Enter", you confirm that you are 21 years of age or older and understand that all products sold on this website are intended for research purposes only.
